Recent News

Share
520 News Items found
Snapshot
Pictured: Nematode Worm Embryo
How to Build a Worm, in 3-D High Definition
Stunning movies captured in the lab of computational biologist Zhirong Bao reveal how cells divide, grow, and move around, as in a carefully choreographed dance, during the development of a nematode worm embryo.
In the Lab
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
Prostate Cancer Organoids Provide New Tool for Evaluating Therapies
Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
In the Lab
Pictured: Johanna Joyce
Researchers Find Clues to How Breast Cancer Can Infiltrate the Brain
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Pictured: Jessica Rios-Esteves
Jessica Rios-Esteves Awarded Chairman’s Prize
Gerstner Sloan Kettering student Jessica Rios-Esteves has been awarded the Chairman’s Prize for her first-author paper published in Cell Reports in 2013.
In the Lab
Lab mouse with cultured human pluripotent stem cells
A New Mouse? Genetically Pliable Stem Cells Could Advance Research on Many Diseases
Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
In the Lab
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
Compound from Tropical Plant Targets Key Cancer-Causing Genes
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now.
Finding
Pictured: Gabriela Chiosis
Hsp90: A Very Promising Target for Cancer Therapy
A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
Feature
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery
Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Decoder
Pictured: Gum ball machines
What Is Tumor Heterogeneity?
Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.
Pictured: 2014 Summer Undergraduate Research Program
Our 2014 Summer Undergraduate Research Program Begins
The Gerstner Sloan Kettering Summer Undergraduate Research Program has welcomed 24 students to Sloan Kettering Institute labs for a ten-week course of study mentored by GSK faculty.